EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Anti-Tumor Effects of Natural Killer Cell-Derived Exosomes Through Doxorubicin Delivery to Hepatocellular Carcinoma Cells: Cytotoxicity and Apoptosis Study

You Hee Choi iD, Ho Yong Kim iD, Jong-Oh Park, Eunpyo Choi iD

International Journal of Molecular Sciences · 01.03.2025 · 26 (5) · 2234

DOI: 10.3390/ijms26052234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.03.2025. Verfasst von You Hee Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Korea Institute of Medical Microrobotics, 43-26 Cheomdangwagi-ro, Buk-gu, Gwangju 61011, Republic of Korea. Hauptthemen laut MEDLINE: Exosomes, Carcinoma, Hepatocellular, Doxorubicin, Liver Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government (MSIP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes are nanosized extracellular vesicles secreted by various cells, including natural killer (NK) cells, and are known for their low toxicity, high permeability, biocompatibility, and strong targeting ability. NK cell-derived exosomes (NK-exos) contain cytotoxic proteins that enhance tumor-targeting efficiency, making them suitable for treating solid tumors such as hepatocellular carcinoma (HCC). Despite their potential in drug delivery, the mechanisms of drug-loaded NK-exos, particularly those loaded with doxorubicin (NK-exos-Dox), remain unclear in HCC. This study explored the anti-tumor effects of NK-exos-Dox against Hep3B cells in vitro. NK-exos-Dox expressed exosome markers (CD9 and CD63) and cytotoxic proteins (granzyme B and perforin) and measured 170–220 nm in size. Compared to NK-exos, NK-exos-Dox enhanced cytotoxicity and apoptosis in Hep3B cells by upregulating pro-apoptotic proteins (Bax, cytochrome c, cleaved caspase 3, and cleaved PARP) and inhibiting the anti-apoptotic protein (Bcl-2). These findings suggest that NK-exos-Dox significantly boost anti-tumor effects by activating specific cytotoxic molecules, offering promising therapeutic opportunities for solid tumor treatment, including HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesCarcinoma, HepatocellularDoxorubicinLiver NeoplasmsKiller Cells, NaturalApoptosisHumansCell Line, TumorDrug Delivery Systems

Stichwörter der Autor:innen

doxorubicinexosomeshepatocellular carcinomaliver cancernatural killer cells

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Korea Institute of Medical Microrobotics, 43-26 Cheomdangwagi-ro, Buk-gu, Gwangju 61011, Republic of Korea.
  • Department of Mechanical Engineering, Sogang University, 35, Baekbeom-ro, Mapo-gu, Seoul 04107, Republic of Korea.

ORCID-Profile: You Hee Choi, Ho Yong Kim, Eunpyo Choi

Förderung

  • National Research Foundation of Korea
  • Korean government (MSIP)

Zitieren

APA

Choi, Y. H., Kim, H. Y., Park, J. O., & Choi, E. (2025). Enhanced Anti-Tumor Effects of Natural Killer Cell-Derived Exosomes Through Doxorubicin Delivery to Hepatocellular Carcinoma Cells: Cytotoxicity and Apoptosis Study. International Journal of Molecular Sciences, 26(5), 2234. https://doi.org/10.3390/ijms26052234

Vancouver

Choi YH, Kim HY, Park JO, Choi E. Enhanced Anti-Tumor Effects of Natural Killer Cell-Derived Exosomes Through Doxorubicin Delivery to Hepatocellular Carcinoma Cells: Cytotoxicity and Apoptosis Study. International Journal of Molecular Sciences. 2025;26(5):2234. doi:10.3390/ijms26052234

BibTeX
@article{Choi2025,
  author = {Choi, You Hee and Kim, Ho Yong and Park, Jong-Oh and Choi, Eunpyo},
  title = {Enhanced Anti-Tumor Effects of Natural Killer Cell-Derived Exosomes Through Doxorubicin Delivery to Hepatocellular Carcinoma Cells: Cytotoxicity and Apoptosis Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {2234},
  doi = {10.3390/ijms26052234}
}
Kostenlos starten →